The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase 1, randomized, open-label, single-dose, crossover study to evaluate the bioequivalence of four formulations of oral rivoceranib tablets in healthy subjects.

Janelle  Weyer

No Relationships to Disclose

Xianzhang  Meng

Employment - Elevar Therapeutics

Stock and Other Ownership Interests  - Elevar Therapeutics

Lynda  Finis

Employment - Elevar Therapeutics

Bill  Strickland

Employment - Elevar Therapeutics

CheolHee  Park

Employment - Elevar Therapeutics

Seong  Jang

Employment - Elevar Therapeutics